{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:40:50Z","timestamp":1785537650835,"version":"3.56.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2010,6,14]],"date-time":"2010-06-14T00:00:00Z","timestamp":1276473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0011089","type":"journal-article","created":{"date-parts":[[2010,6,14]],"date-time":"2010-06-14T20:47:32Z","timestamp":1276548452000},"page":"e11089","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":75,"title":["Serum S100B: A Potential Biomarker for Suicidality in Adolescents?"],"prefix":"10.1371","volume":"5","author":[{"given":"Tatiana","family":"Falcone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damir","family":"Janigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,6,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/08039480801959273","article-title":"Subjective psychological well-being (WHO-5) in assessment of the severity of suicide attempt.","volume":"62","author":"M Sisask","year":"2008","journal-title":"Nord J Psychiatry"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.psyneuen.2008.05.012","article-title":"Salivary cortisol and suicidal behavior\u2013a follow-up study.","volume":"33","author":"D Lindqvist","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biopsych.2009.01.030","article-title":"Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.","volume":"66","author":"D Lindqvist","year":"2009","journal-title":"Biol Psychiatry"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-2478(98)00145-X","article-title":"Immune activation in non-treated suicidal major depression.","volume":"67","author":"S Mendlovic","year":"1999","journal-title":"Immunol Lett"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","article-title":"The macrophage theory of depression.","volume":"35","author":"RS Smith","year":"1991","journal-title":"Med Hypotheses"},{"key":"ref6","first-page":"21S","article-title":"Prediction of suicidal behavior from biologic tests.","volume":"12","author":"L Traskman-Bendz","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0447.2007.01128.x","article-title":"Elevated cytokine expression in the orbitofrontal cortex of victims of suicide.","volume":"117","author":"LH Tonelli","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.pnpbp.2007.08.041","article-title":"Differences in cytokines between non-suicidal patients and suicidal patients in major depression.","volume":"32","author":"YK Kim","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.pnpbp.2006.04.008","article-title":"Increased plasma nitric oxide level associated with suicide attempt in depressive patients.","volume":"30","author":"YK Kim","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0920-9964(00)00156-0","article-title":"Neuroleptics normalize increased release of interleukin- 1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia.","volume":"50","author":"J Kowalski","year":"2001","journal-title":"Schizophr Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nrn1220","article-title":"Neurobiology of suicidal behaviour.","volume":"4","author":"JJ Mann","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.biopsych.2009.06.005","article-title":"Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.","volume":"66","author":"JM Meyer","year":"2009","journal-title":"Biol Psychiatry"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0304-3940(99)00545-5","article-title":"Evidence for activation of microglia in patients with psychiatric illnesses.","volume":"271","author":"TA Bayer","year":"1999","journal-title":"Neurosci Lett"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jnen\/59.2.137","article-title":"Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics.","volume":"59","author":"K Radewicz","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref15","first-page":"157","article-title":"Degeneration of microglial cells in frontal and temporal lobes of chronic schizophrenics.","volume":"42","author":"T Wierzba-Bobrowicz","year":"2004","journal-title":"Folia Neuropathol"},{"key":"ref16","first-page":"81","article-title":"Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics.","volume":"43","author":"T Wierzba-Bobrowicz","year":"2005","journal-title":"Folia Neuropathol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpsychires.2006.10.013","article-title":"Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide.","volume":"42","author":"J Steiner","year":"2008","journal-title":"J Psychiatr Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00401-006-0090-8","article-title":"Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization.","volume":"112","author":"J Steiner","year":"2006","journal-title":"Acta Neuropathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/070674370304800504","article-title":"The neurobiology of suicide and suicidality.","volume":"48","author":"K Van Heeringen","year":"2003","journal-title":"Can J Psychiatry"},{"key":"ref20","article-title":"Interlukin-1B and self-inflicted aggressive behavior.","volume":"1","author":"S Westlin","year":"2009","journal-title":"Neurology Psychiatry and Brain Research Supplement"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0924-977X(96)00020-X","article-title":"Impairment of the blood-CSF barrier in suicide attempters.","volume":"6","author":"L Bayard-Burfield","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2003.12.008","article-title":"Peripheral markers of blood-brain barrier damage.","volume":"342","author":"N Marchi","year":"2004","journal-title":"Clin Chim Acta"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/cncr.11409","article-title":"Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions.","volume":"97","author":"AA Kanner","year":"2003","journal-title":"Cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1523\/JNEUROSCI.23-05-01949.2003","article-title":"Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption.","volume":"23","author":"N Marchi","year":"2003","journal-title":"J Neurosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/cncr.21220","article-title":"S100beta as a predictor of brain metastases: brain versus cerebrovascular damage.","volume":"104","author":"MA Vogelbaum","year":"2005","journal-title":"Cancer"},{"key":"ref26","first-page":"109","article-title":"Peripheral markers of brain damage and blood-brain barrier dysfunction.","volume":"21","author":"N Marchi","year":"2003","journal-title":"Restor Neurol Neurosci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0006-8993(02)02586-6","article-title":"Serum S-100beta as a possible marker of blood-brain barrier disruption.","volume":"940","author":"M Kapural","year":"2002","journal-title":"Brain Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1528-1167.2007.00988.x","article-title":"Seizure-promoting effect of blood-brain barrier disruption.","volume":"48","author":"N Marchi","year":"2007","journal-title":"Epilepsia"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/01.shk.0000209534.61058.35","article-title":"Serum S-100B concentration provides additional information fot the indication of computed tomography in patients after minor head injury: a prospective multicenter study.","volume":"25","author":"P Biberthaler","year":"2006","journal-title":"Shock"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jad.2008.03.005","article-title":"Serum markers support disease-specific glial pathology in major depression.","volume":"111","author":"ML Schroeter","year":"2008","journal-title":"J Affect Disord"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/104454601750143500","article-title":"A revised anchored version of the BPRS-C for childhood psychiatric disorders.","volume":"11","author":"CW Hughes","year":"2001","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1176\/ajp.151.2.249","article-title":"Assessing positive and negative symptoms in children and adolescents.","volume":"151","author":"JH Fields","year":"1994","journal-title":"Am J Psychiatry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.mp.4000889","article-title":"Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology.","volume":"6","author":"M Rothermundt","year":"2001","journal-title":"Mol Psychiatry"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00213-004-1999-z","article-title":"The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment.","volume":"178","author":"G Hetzel","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1528-1167.2006.00817.x","article-title":"The blood-brain barrier and epilepsy.","volume":"47","author":"E Oby","year":"2006","journal-title":"Epilepsia"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nbd.2008.10.002","article-title":"Antagonism of peripheral inflammation reduces the severity of status epilepticus.","volume":"33","author":"N Marchi","year":"2009","journal-title":"Neurobiol Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0074-7742(04)59017-7","article-title":"S100B in schizophrenic psychosis.","volume":"59","author":"M Rothermundt","year":"2004","journal-title":"Int Rev Neurobiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1089\/neu.2008.0738","article-title":"Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.","volume":"26","author":"BJ Blyth","year":"2009","journal-title":"J Neurotrauma"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s002680020370","article-title":"Evaluation of S-100b as a specific marker for neuronal damage due to minor head trauma.","volume":"25","author":"P Biberthaler","year":"2001","journal-title":"World J Surg"},{"key":"ref40","first-page":"393","article-title":"S-100b as a screening marker of the severity of minor head trauma (MHT)\u2013a pilot study.","volume":"Suppl 76","author":"T Mussack","year":"2000","journal-title":"Acta Neurochir"},{"key":"ref41","first-page":"164","article-title":"Rapid identification of high-risk patients after minor head trauma (MHT) by assessment of S-100B: ascertainment of a cut-off level.","volume":"7","author":"P Biberthaler","year":"2002","journal-title":"Eur J Med Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.psychres.2008.01.002","article-title":"Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia\u2013original research and meta-analysis.","volume":"167","author":"ML Schroeter","year":"2009","journal-title":"Psychiatry Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/mp.2008.85","article-title":"Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders.","volume":"14","author":"ML Schroeter","year":"2009","journal-title":"Mol Psychiatry"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1528-1167.2007.01135.x","article-title":"Glial activation links early-life seizures and long-term neurologic dysfunction: evidence using a small molecule inhibitor of proinflammatory cytokine upregulation.","volume":"48","author":"KC Somera-Molina","year":"2007","journal-title":"Epilepsia"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1089\/neu.2008.0753","article-title":"Pediatric brain trauma outcome prediction using paired serum levels of inflammatory mediators and brain-specific proteins.","volume":"26","author":"TY Lo","year":"2009","journal-title":"J Neurotrauma"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e5759","DOI":"10.1371\/journal.pone.0005759","article-title":"Does pilocarpine-induced epilepsy in adult rats require status epilepticus?","volume":"4","author":"MG Navarro","year":"2009","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ajmg.b.30950","article-title":"Risk variants in the S100B gene predict elevated S100B serum concentrations in healthy individuals.","volume":"153B","author":"C Hohoff","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0011089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:41:34Z","timestamp":1740181294000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0011089"}},"subtitle":[],"editor":[{"given":"Kenji","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,6,14]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2010,6,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0011089","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,14]]}}}